高川哲也

Takagawa Tetsuya

所属機関・部署：

研究分野 (1件)：消化器内科学

研究キーワード (4件)：クローン病 , 潰瘍性大腸炎 , 粘膜免疫 , 炎症性腸疾患

競争的資金等の研究課題 (3件)：

論文 (13件)：

Yoichi Kakuta, Yosuke Kawai, Daisuke Okamoto, Tetsuya Takagawa, Kentaro Ikeya, Hirotake Sakuraba, Atsushi Nishida, Shoko Nakagawa, Miki Miura, Takahiko Toyonaga, et al. NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study. Journal of gastroenterology. 2018. 53. 9. 1065-1078
Tetsuya Takagawa, Atsushi Kitani, Ivan Fuss, Beth Levine, Steven R. Brant, Inga Peter, Masaki Tajima, Shiro Nakamura, Warren Strober. An increase in LRRK2 suppresses autophagy and enhances dectin-1-induced immunity in a mouse model of colitis. Science Translational Medicine. 2018. 10. 444
Kazutoshi Hori, Tetsuya Takagawa, Nobuyuki Hida, Shiro Nakamura. Safety of one-week, first-line, standard triple therapy for Helicobacter pylori eradication in a Japanese population. Current Drug Safety. 2017. 12. 2. 103-109
Toshiyuki Sato, Tetsuya Takagawa, Yoichi Kakuta, Akihiro Nishio, Mikio Kawai, Koji Kamikozuru, Yoko Yokoyama, Yuko Kita, Takako Miyazaki, Masaki Iimuro, et al. NUDT15, FTO, and RUNX1 genetic variants and thiopurine intolerance among Japanese patients with inflammatory bowel diseases. Intestinal Research. 2017. 15. 3. 328-337
Kazutoshi Hori, Yoshi-Hiro Ide, Seiichi Hirota, Fumihiko Toyoshima, Tetsuya Takagawa, Shiro Nakamura. Early gastric adenocarcinoma of the fundic gland type. ENDOSCOPY. 2015. 47. E177-E178

MISC (47件)：

学歴 (2件)：

経歴 (4件)：

受賞 (3件)：

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

高川 哲也